Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study
In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the sid...
Saved in:
Main Authors: | Nishat Jahan (Author), Fahad Imtiaz Rahman (Author), Poushali Saha (Author), Sadia Afruz Ether (Author), ASM Roknuzzaman (Author), Rapty Sarker (Author), Khondoker Tashya Kalam (Author), Kashfa Haq (Author), Julkar Nyeen (Author), Humayra Zaman Himi (Author), Md. Nazmul Hossain (Author), Mahtab Hossain Chowdhury (Author), Mostafa Moin Uddin (Author), Nur Haque Alam (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Busting the Breast Cancer with AstraZeneca's Gefitinib
by: S. Chemmalar, et al.
Published: (2023) -
Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023) -
New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022) -
[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
by: N. González-Romero, et al.
Published: (2022) -
A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
by: Reema Madike, et al.
Published: (2023)